Skip to main content

Find Clinical Trials

Home
Conditions
Establish the Amount of CENPV Protein in Human Oocytes As a Diagnostic Tool Against Damage Caused by Ageing or by the Procedure of Vitrification of Oocytes

Clinical trial condition

Establish the Amount of CENPV Protein in Human Oocytes As a Diagnostic Tool Against Damage Caused by Ageing or by the Procedure of Vitrification of Oocytes

Explore clinical trials studying Establish the Amount of CENPV Protein in Human Oocytes As a Diagnostic Tool Against Damage Caused by Ageing or by the Procedure of Vitrification of Oocytes. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Establish the Amount of CENPV Protein in Human Oocytes As a Diagnostic Tool Against Damage Caused by Ageing or by the Procedure of Vitrification of Oocytes trial results

Recruiting

CENP-V As a Potential Diagnostic Marker of Damage in Human Oocytes

NCT06788379

Conditions: Advance Maternal Age, Establish the Amount of CENPV Protein in Human Oocytes As a Diagnostic Tool Against Damage Caused by Ageing or by the Procedure of Vitrification of Oocytes, Vitrification and Thawing
Locations: Vida Recoletas Sevilla S.L. Seville, SEVILLA, Spain

View Trial Details